SCHEMBL19082383

SCHEMBL19082383

c1ccc2c(-c3c4ccccc4c(-c4ccc5cc(-c6cc7sc8c9ccccc9ccc8c7c7sc8ccccc8c67)ccc5c4)c4ccccc34)cccc2c1

nearest known ligand 0.38

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 1/20 0.38
CYP1A1 P04798 5/20 0.36
CYP1B1 Q16678 5/20 0.36
CYP1A2 P05177 3/20 0.36
S1PR5 Q9H228 8/20 0.35
S1PR4 O95977 6/20 0.35
CA12 O43570 2/20 0.34
CA1 P00915 2/20 0.34
CA2 P00918 2/20 0.34
CA9 Q16790 2/20 0.34
PTPN1 P18031 1/20 0.33
PIM1 P11309 1/20 0.32
NQO1 P15559 1/20 0.32
NQO2 P16083 1/20 0.32
HDAC4 P56524 1/20 0.32
HDAC2 Q92769 1/20 0.32
HDAC8 Q9BY41 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17945735 0.97 ALOX5 (0.39) ALOX5CYP1A1CYP1B1CYP1A2S1PR5
SCHEMBL19082239 0.93 CA12 (0.38) ALOX5CYP1A1CYP1B1CYP1A2S1PR5
SCHEMBL19082347 0.91 CYP1A1 (0.40) ALOX5CYP1A1CYP1B1CYP1A2S1PR5
SCHEMBL17945710 0.90 ALOX5 (0.38) ALOX5CYP1A1CYP1B1CYP1A2CA12
SCHEMBL19082293 0.90 CYP1A1 (0.36) ALOX5CYP1A1CYP1B1CYP1A2S1PR5
SCHEMBL19080349 0.90 CYP1A1 (0.39) ALOX5CYP1A1CYP1B1CYP1A2S1PR5
SCHEMBL19082114 0.89 CYP1A1 (0.39) ALOX5CYP1A1CYP1B1CYP1A2CA12
SCHEMBL19082387 0.89 CYP1A1 (0.35) ALOX5CYP1A1CYP1B1CYP1A2S1PR5
SCHEMBL19082173 0.89 CYP1A1 (0.39) ALOX5CYP1A1CYP1B1CYP1A2S1PR5
SCHEMBL17945706 0.88 CA12 (0.40) ALOX5CYP1A1CYP1B1CYP1A2CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-02-04 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNT1 ALOX5 1939/4885CYP1A1 184/4885CYP1B1 260/4885
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNT1 ALOX5 1939/4885CYP1A1 184/4885CYP1B1 260/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.